Inflexion reaps 2.8x on £42m Phlexglobal sale to BDC
Inflexion Private Equity has sold Phlexglobal to Bridgepoint Development Capital (BDC) for £42m, generating a 2.8x return on its original investment.
More on Buyouts
Sagard invests in Flight Simulator developer Asobo Studio
Deal is the second for the Sagard NewGen fund, launched in July 2020 with a €300m target
Baird sells Prescient to BDC
In November 2020, the vendor requested another set of indicative offers from seven or eight bidders
Oaktree Capital backs Col Giovanni Paolo
With the GP's support, the company plans to consolidate its market position and boost its international expansion
Heritage Ventures buys ICT specialist Metoda
GP intends to boost the company's growth and double its revenues in the next five years
Latest News
LP Profile: IMCO
Managing director Craig Ferguson discusses accelerated deployment activity during the pandemic and plans to scale up the PE allocation by 2025
Elbrus holds first close on $260m for third fund – report
Fund has a target of $600m, which it plans to reach by next year, according to Kommersant
Alta Life Sciences invests in Inbiomotion
Existing investors including Institut Català de Finances also take part in the financing
Korys, FPIM et al. in €12m extended series-B for Remynd
Biotech company initially raised €12m in December 2018